|
New Page 1
|
|
New Page 1
|
|
Article Summary |
 |
|
|
Parkinson's Drug Pulled from US Market
(AFP, 3/30/07)
The FDA announced that the manufacturers of the
Parkinson's drug pergolide, marketed as Permax and in two
generic forms, will stop selling it in the US based on
evidence that demonstrate that it significantly raises the
risk of heart valve damage. Two studies in the New England
Journal of Medicine confirm previous findings linking
pergolide to a condition known as valve regurgitation, where
the valves do not close tightly enough to block the backflow
of blood. The FDA advised patients to contact their doctors
and not just abruptly discontinue the medication. |
|
|
New Page 1
|
Disclaimer: SmartTrac Computer Systems, Inc. does not warrant that the
information on this website is free of errors, inaccuracies or omissions. The
content of this website is presented for educational purposes only. It is
not intended as a substitute for the diagnosis, treatment and advice of a
qualified licensed professional.
© 2004-2007, SmartTrac Computer Systems, Inc.
All rights reserved.
The content of Health News Express is the intellectual property
of SmartTrac Computer Systems, Inc. Any use of the materials presented on
this website is expressly prohibited without prior written consent. |
|
|
